GCMAF

treatment for cancer, aids and immune diseases

  • Increase font size
  • Default font size
  • Decrease font size
Home Published patient trials The glycosylation of GcMAF: T420

The glycosylation of GcMAF: T420

 The vitamin D binding protein, Gc globulin, has in recent years received some attention for its role as precursor for the extremely potent macrophage activating factor (GcMAF). An O-linked trisaccharide has been allocated to the threonine residue at position 420 in two of the three most common isoforms of Gc globulin (Gc1s and Gc1f). A substitution for a lysine residue at position 420 in Gc2 prevents this isoform from being glycosylated at that position. It has been suggested that Gc globulin subjected sequentially to sialidase and galactosidase treatment generates GcMAF in the form of Gc globulin with only a single GalNAc attached to T420.

In this study we confirm the location of a linear trisaccharide on T420. Furthermore, we provide the first structural evidence of the generation of the proposed GcMAF by use of glycosidase treatment and mass spectrometry. Additionally the generated GcMAF candidate was tested for its effect on cytokine release from macrophages in human whole blood.

 

The glycosylation and characterization of the candidate Gc macrophage activating factor.
MedLine Citation:
PMID:  20079467     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The vitamin D binding protein, Gc globulin, has in recent years received some attention for its role as precursor for the extremely potent macrophage activating factor (GcMAF). An O-linked trisaccharide has been allocated to the threonine residue at position 420 in two of the three most common isoforms of Gc globulin (Gc1s and Gc1f). A substitution for a lysine residue at position 420 in Gc2 prevents this isoform from being glycosylated at that position. It has been suggested that Gc globulin subjected sequentially to sialidase and galactosidase treatment generates GcMAF in the form of Gc globulin with only a single GalNAc attached to T420. In this study we confirm the location of a linear trisaccharide on T420. Furthermore, we provide the first structural evidence of the generation of the proposed GcMAF by use of glycosidase treatment and mass spectrometry. Additionally the generated GcMAF candidate was tested for its effect on cytokine release from macrophages in human whole blood.
Authors:
Tina Ravnsborg; Dorthe T Olsen; Anna Hammerich Thysen; Maja Christiansen; Gunnar Houen; Peter H??jrup
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2010-1-13
Journal Detail:
Title:  Biochimica et biophysica acta     Volume:  1804     ISSN:  0006-3002     ISO Abbreviation:  -     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-2-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0217513     Medline TA:  Biochim Biophys Acta     Country:  -    
Other Details:
Languages:  ENG     Pagination:  909-917     Citation Subset:  -    
Copyright Information:
Copyright ?? 2010 Elsevier B.V. All rights reserved.
Affiliation:
Institute of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

 

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Source: http://www.biomedsearch.com/nih/glycosylation-characterization-candidate-Gc-macrophage/20079467.html